AzTrials
AzTrials

Premature BirthNCT04563364

Interdisciplinary Hospital-home Intervention on Motor Development in Premature Children

A study testing Interdisciplinary hospital-home intervention and Convencional treatment in people with Premature Birth, run by Universidad de la Sabana at 1 site in Colombia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Motor development of the premature infant often exhibits deviations that trigger functional limitations and disability. In Colombia, one out of every five births corresponds to premature babies. Read more about this study

Who is it for?
Ages 34 to 37 weeksHealthy volunteers can take part
Conditions the study is for
Premature Birth
What is being tested?
Interdisciplinary hospital-home intervention and Convencional treatment
Could I receive a placebo?
No, everyone receives an active treatment
How many people
130 participants
Where
1 siteColombia
Study dates
1 Oct 2021to 29 Jul 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 34 to 37 weeks
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Premature infants between 34 and 37 weeks of gestation,
  • Infants with weight over 1800gr
  • Hemodynamic stability
  • Interns in NICU of participants institutions (Colombia and Poland).
  • Infants with residence in a places close to the institutional health care services.

Who cannot join

  • Premature child with a musculoskeletal deformity.
  • Premature child with diagnosis of a genetic syndrome
  • Premature child with congenital heart diseases.
  • Premature child with brain injuries.

Trial locations and contacts

1 site in 1 country.

Colombia1 site
  • Hospital San Rafael

    Tunja

Other trials in Colombia

About this study

Official title: Interdisciplinary Hospital-home Intervention on the Adaptation of Motor Development in Premature Children.Randomized Clinical Trial

Motor development of the premature infant often exhibits deviations that trigger functional limitations and disability. In Colombia, one out of every five births corresponds to premature babies. In preterm infants requiring hospitalization, early clinical interventions focused on home care have been shown to improve motor development and decrease morbidity.

However, interdisciplinary work, supported by information and communication Technologies (ICT), shows a knowledge gap that can be explored. This leads to the following research question: ¿What is the effect of an interdisciplinary Hospital-Home intervention addressing motor development adaptation in premature infants in Colombia in comparison with traditional interventions?

Read more

Objective: To determine the effect of an interdisciplinary Hospital-Home intervention addressing motor development adaptation in premature infants in Colombia in comparison with traditional interventions

Methodology Experimental quantitative study with pre-test and post-test to two groups, experimental and control, which compares before and after the intervention. The intervention will be developed in two scenarios: the hospital and the home. The experimental group will receive the intervention and the control group the traditional care established in the institutions for premature children. The calculation of the sample size is 130 participants.

Type of results expected to be obtained It is expected to obtain a supported that justifies the importance of education from hospital stay, post discharge follow-up and parental participation in the adequate stimulation of motor development of the premature. It is expected to incorporate the use of ICT in home monitoring, while implementing the use of a mobile application for this purpose. It is also expected to contribute to the research training of undergraduate and graduate students. In addition, participate in national and international presentations and in the production of scientific articles.

Conditions
Premature Birth
Being tested
Interdisciplinary hospital-home intervention, Convencional treatment
Keywords
Infant, Child Development, Nursing, Physical Therapy Specialty
Medical subject headings
Premature Birth

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Interdisciplinary hospital-home interventionOther

    The intervention will start in NICU and to be continued at home with the support of ICT. The NICU intervention will have theoretical and practical components, the theoretical one will be about motor development in premature infants, and practical one will have strategies for motor early intervention, it will be demonstrated with pediatric simulator and parents should be demonstrate it with a infant: 1Sensorial motor stimulation, visual and auditory follow-6up; Tactile integration 3Extension muscle activation 4Middle line integration 5Alignment reaction stimulation in prone position 6Flexor muscle activation with transition to lateral position 7Flexor muscle activation with transition to sitting position 8Facilitation of reciprocal flexion and extension lower limbs. All parents will receive a motor sensorial kit that will include roller, visual tags, blankets and rattles, it will be for apply the strategies for motor early intervention, and will be supported by ICT

  • Convencional treatmentOther

    Control group will receive a conventional treatment given by the institutions

Study groups in NCT04563364
Study groupRoleWhat they receive
Hospital-HomeExperimentalThis group will receive an interdisciplinary intervention of education to parents for get better outcomes of motor development.
Receives: Other: Interdisciplinary hospital-home intervention
Control InterventionActive comparatorControl group will receive a conventional treatment given by the institutions
Receives: Other: Convencional treatment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Motor Development.

    Test on infant motor performance (TIMPSI)

    Measured: 18 Months

Secondary outcomes (1)
  1. CapDMP questionnaire

    Questionnaire that measure the degree of knowledge in parents or caregivers about motor development in premature

    Measured: From enrollment to the end of treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Sep 2020
  2. Study start1 Oct 2021
  3. Primary completion15 Mar 2023
  4. Study completion29 Jul 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Care provider, Outcomes assessor
Enrolment
130 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04563364
Sponsor's protocol ID
ENF-32-2019
Status last verified
Mar 2025
First submitted
25 Aug 2020
Last updated
30 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Sandoval-Cuellar C, Castellanos-Garrido AL, Ospina Romero AM, Boude Figueredo OR, Serrano-Gomez ME, Fuya Caro CA, Molina Cardenas DC, Pinto Rosas EM. Motor development in premature infants: Study protocol for an interdisciplinary hospital-home intervention. Pediatr Neonatol. 2023 Sep;64(5):577-584. doi: 10.1016/j.pedneo.2022.12.015. Epub 2023 Mar 15.

    PubMed 37002053

Questions about this trial

What is this clinical trial studying?

A study testing Interdisciplinary hospital-home intervention and Convencional treatment in people with Premature Birth, run by Universidad de la Sabana at 1 site in Colombia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Colombia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Motor Development. (time frame: 18 Months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04563364, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in